Should a nursing home adopt a flu immunization program? How effective are wellness center programs that are designed to reduce high blood pressure in adults? How often should a child be screened for lead poisoning? Many people might be surprised to learn that economics helps answer these questions. It may be hard to imagine economists studying health and medicine, but it turns out that they help public-health officials and health-care providers by determining the efficient allocation of scarce health-care resources.
Implementing a new health program or maintaining the current one eventually leads to several questions: Is the program worth it? Do the time and effort of the program provide a benefit to the recipients? Is there a more efficient way to carry out the program? Health economists apply economic evaluations to assist in answering these questions. The basic idea behind any economic evaluation is to compare the costs and benefits related to some decision.
In looking for a program's cost to society, some people might examine only the program's budget. Salaries for nurses and doctors, expenses for educational brochures and other financial or accounting costs will appear in the budget. But such an examination of the budget ignores the program's economic costs or opportunity costs to society, which are what economists look for.
Opportunity costs can be thought of in terms of trade-offs. Every time you do something, you forgo doing something else. Choosing between going to a baseball game and a hockey game means you give up one to see the other. So, when economists look for a program's opportunity costs, they consider the trade-off of devoting resources to establishing and carrying out that program instead of using them for something else.
Economic costs paint a better picture of a program's true costs and provide a common yardstick to compare different programs. Consider, for example, the difference between economic and financial costs of a volunteer. Suppose a flu vaccination program relies on volunteer help for some of its daily activities. Although the use of volunteers does not impose a financial cost on the program, it does impose a cost to society because the volunteers' time could be used elsewhere, including helping out in another program.
With this idea in mind, the resources used by a program can be divided into four categories: (1) resources used directly from within the health industry, (2) resources used by the program's participants, (3) resources used to treat side effects and (4) resources from other programs.1
Most of a program's direct costs come from resources used within the health industry, mostly wages paid to personnel who provide the service or activity but also the value of volunteer time given to the program. Other direct program costs can include donated goods, materials and supplies, laboratory equipment and any space used by the program, whether an existing or new facility.
The participants' costs vary, depending on what they must give up to participate in the program. Resources used by program participants can be special items purchased for use in that program, as well as transportation to and from the program site. Another cost to a participant is what economists label productivity loss, which simply refers to the foregone wages because of time taken away from work.2 This time consists of travel time, waiting time and the actual time spent in the program.
Economists also consider indirect costs, such as adverse side effects resulting from the program. For example, every individual has a small chance of developing a reaction to a flu shot. A reaction to the flu shot given through a flu vaccination program requires additional care; so, the extra costs for this treatment should also be included in the cost of the program.
Another indirect cost comes in the form of resources taken away from other programs. For example, if a nursing home is deciding whether to begin a flu vaccination program, the home should consider the resources that will be diverted from other activities to make the vaccination program possible.
Once economists identify the costs associated with implementing a health program, they consider the outcomes of the program. Two methods for measuring health outcomes are cost-benefit analysis and cost-effectiveness analysis.3 A cost-benefit analysis puts dollar values on all costs and benefits related to a program. If the net cost, that is, total benefits minus total costs, is greater than zero, then a program has a net beneficial effect and should be carried out. This type of analysis can be used to decide whether to pursue a particular program or choose among programs with different health outcomes. Health outcomes may be valued using the willingness-to-pay method.4 This measurement technique tries to gauge how much society is willing to pay to lower the risk of death due to a specific illness or disease. For example, consider a group of 100,000 people who participate in a flu shot program. Let's assume five will die of the flu. If all are willing to pay $10 each to reduce the number of flu-related deaths to three, then the "value" per life saved is $500,000 (100,000 people X $10 per person = $1,000,000 ÷ 2 lives saved = $500,000 per life saved).
This example illustrates two disadvantages to cost-benefit analysis:
Unlike a cost-benefit analysis, a cost-effectiveness analysis does not assign a dollar value to each outcome. Instead, it measures outcomes using an effectiveness measure that is specific to the program being evaluated; for a flu shot program, it would likely be the reduction in the percentage of people who get the flu.5
Cost-effectiveness analysis is beneficial when comparing programs with common outcomes, such as a flu program in a hospital with a flu program in a nursing home. Rather than measuring what society is willing to pay to avoid a disease or illness, health outcomes are thought of in terms of the costs that are saved as a result of the program. Ill people incur medical costs for treatment and lost income due to time taken away from work. Because the program saves the costs by preventing illness, the costs are subtracted from the cost of implementing the program to arrive at the program's net cost. For a flu program, this net cost is then divided by the number of flu cases prevented to obtain a cost for each flu case prevented.
So, how have economic evaluations been used? The accompanying table shows the results of a few cost-benefit studies that estimate the benefit of flu vaccinations in healthy, working adults. The costs were not estimated using the willingness-to-pay method. A minus before a cost (as in –$6.65) means society does not receive a benefit in that cost category. The net cost savings range from $13.66 to $83.84.
The results from these studies vary because of different study settings, different prices used to estimate costs and different assumptions about the amount of medical care needed to treat the flu. Despite these differences, the studies suggest that, overall, society benefits from flu vaccinations.
How does figuring the costs and benefits of a health program help us out? Economic evaluations go beyond pure efficacy of health programs and determine the efficient allocation of scarce health resources. They provide a very useful framework that helps policy-makers in Washington make better decisions when thinking about which health programs to endorse and fund. Simply put, economic evaluations allow our country's leaders to choose the health programs that provide the greatest benefit to our society.
|Study||Direct Cost Savings Per Person||Indirect Cost Savings Per Person||Not Cost savings Per Person|
|Nichol et al. (1995)||$5.99||$40.86||$46.85|
Dille, JoAnne Hein. "A Worksite Influenza Immunization Program." Official Journal of the American Association of Occupational Health Nurses, July 1999, Vol. 47, No. 7, pp. 301-9.
Drummond, Michael; O'Brien, Bernie; Stoddart, Greg and Torrance, George, eds. Methods for the Economic Evalua-tion of Health Care Programmes. Oxford: Oxford University Press, 1997.
Haddix, Anne C.; Teutsch, Steven M.; Shaffer, Phaedra and Dunet, Diane, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. Oxford: Oxford University Press, 1996.
Nichol, Kristin L. "Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza." Archives of Internal Medicine, March 2001, Vol. 161, pp. 749-59.
__________; Lind, April; Margolis, Karen L.; Murdoch, Maureen; McFadden, Rodney; Hauge, Meri; Magnan, Sanne and Drake, Mari. "The Effectiveness of Vaccination against Influenza in Healthy, Working Adults." The New England Journal of Medicine, October 1995, Vol. 333, No. 14, pp. 889-93.
Keep up with what’s new and noteworthy at the St. Louis Fed. Sign up now to have this free monthly e-newsletter emailed to you.